July 12, 2014 4:03 PM ET

Pharmaceuticals

Company Overview of Limerick BioPharma, Inc.

Executive Profile

Ivan Lieberbug M.D., Ph.D.

Member of Scientific Advisory Board, Limerick BioPharma, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background

Ivan Lieberbug, MD, PhD serves as a Member of the Tavistock Group, where he concentrates on health care and life sciences opportunities. Prior to joining Tavistock in 2009, Dr. Lieberbug was employed at Elan, plc, for 22 years, where he served as Executive Vice President of Corporate Office of Technology and Chief Medical Officer. Other senior positions at Elan that he held included Chief Scientific Officer and Senior Vice President of Research. Dr. Lieberbug has been ...

Corporate Headquarters

601 Gateway Boulevard
South San Francisco, California 94080

United States

Phone: 650-742-0110
Fax: 650-742-0111

Board Members Memberships

There is no Board Members Memberships data available.

Education

BA 1971
Cornell University
MD 1980
University Of Miami School Of Medicine

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Limerick BioPharma, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.